Digital Healthcare Platform Surges on Record Order Growth

The digital healthcare sector continues to gain momentum as investors recognize the massive shift toward telehealth and remote patient care. With an aging population, rising healthcare costs, and increasing demand for convenient medical services, companies that can successfully scale their digital platforms are attracting significant attention from growth-focused investors.

Shareholders of Hydreight Technologies Inc. (TSX-V: NURS) (OTCQB: HYDTF) are celebrating today after the company reported record-breaking order growth through its flagship VSDHOne platform, with July orders exceeding projections by over 300%, sending shares significantly higher in morning trading.

The company’s VSDHOne platform, a fully compliant, tech-enabled ecosystem connecting prescribers, pharmacies, and patients nationwide, delivered exceptional performance in recent months, with July far surpassing internal forecasts. While June achieved approximately 7,187 SKU orders (within the 7,000-10,000 projection range), July exploded to approximately 35,642 SKU orders against a forecast of just 10,000, representing more than triple the expected volume.

This momentum is accelerating into August, where Hydreight is targeting approximately 55,000 SKU orders as the company races toward its 2025 goal of 1.3 million total orders. The surge comes as Hydreight has invested heavily in enhancing the VSDHOne technology platform into a fully modular architecture, enabling businesses to seamlessly onboard and adopt only the components they need to generate orders.

“We are seeing rapid momentum across the VSDHOne network,” said Shane Madden, CEO of Hydreight Technologies. “July’s high 2,000 daily orders are already being surpassed as we enter August. This growth trajectory gives us full confidence in achieving our target of 1.3 million total orders for the year.”

A key driver behind this explosive growth is Hydreight’s strategic partnership with Perfect Scripts, announced in July, which provides nationwide API integration that automates prescription processing and eliminates bottlenecks. Perhaps more importantly, the partnership gives Hydreight access to 503B outsourcing facilities, a federal designation allowing for large-batch, sterile drug compounding under stringent FDA quality standards. This capability enables the company to manufacture and ship high-demand medications at scale without the prescription-by-prescription constraints of traditional compounding.

Adding to the growth momentum, Hydreight is launching Hydreight Marketing Solutions, a wholly owned subsidiary dedicated to providing turnkey marketing services to its licensees and telehealth partners. The new division will deliver data-driven campaigns and patient acquisition strategies designed specifically for healthcare providers on the VSDHOne platform, with client-level marketing success translating directly to higher patient volumes and order growth across the network.

“When our clients grow, we grow,” Madden explained. “Hydreight Marketing Solutions is about giving every partner on our platform the ability to market like a national brand, even if they’re a single provider. That means more patients served, more orders processed, and more revenue for everyone in the network.”

Canadian shares of NURS are ahead 15.8% at C$3.15 in Tuesday morning trading, while U.S. shares are up 16.5% at $2.31.

Copyright © 2025 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com’s content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

View more of this article on AllPennyStocks.com.

About AllPennyStocks.com Media, Inc.:

Founded in 1999, AllPennyStocks.com is one of North America’s leading platforms for micro-cap insights.

Catering to both Canadian and U.S. markets, we provide a wealth of resources and expert content designed for everyone—from beginner investors to seasoned traders.

AllPennyStocks.com is rapidly gaining recognition as a leading authority in the micro-cap space, with our insightful content prominently featured across numerous top-tier financial platforms, reaching a broad audience of investors and industry professionals.

Want to showcase your company’s story to a powerful network of investors? We can help you elevate your message and make a lasting impact. Contact us today.

Contact:

AllPennyStocks.com Media, Inc.

Email: [email protected]

Phone: (800) 558-4560 Ext: 101